We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Artificial Intelligence Can Detect Glucose Levels via ECG

By HospiMedica International staff writers
Posted on 20 Jan 2020
Print article
Image: ECG heartbeat segments help identify hypoglycemia events (Photo courtesy of University of Warwick)
Image: ECG heartbeat segments help identify hypoglycemia events (Photo courtesy of University of Warwick)
A new study shows how artificial intelligence (AI) can be used to detect hypoglycemic events from raw electrocardiogram (ECG) signals.

Developed at the University of Warwick (Coventry, United Kingdom), the University of Napoli Federico II (Naples, Italy), Western University (WU; London, Canada), and other institutions, the personalized medicine approach uses AI to automatically detect nocturnal hypoglycemia with just a few heartbeats of raw ECG signal recorded with non-invasive, wearable devices. A visualization method then enables the clinicians to establish which part of the ECG signal is significantly associated with a hypoglycemic event in each individual subject.

The AI model is trained with each subject's own dataset, which is comprised of both ECG and glucose recordings as measured by two sensors worn for a period of 8-14 days. The researchers conducted two pilot studies involving eight healthy volunteers, which found that the average sensitivity and specificity of the AI approach for hypoglycemia detection was about 82%, comparable to current continuous glucose monitoring (CGM) device performance. The study was published on January 13, 2020, in Nature Scientific Reports.

“Fingerpicks are never pleasant, and in some circumstances particularly cumbersome. Our innovation consisted of using AI for automatically detecting hypoglycemia via few ECG beats. This is relevant because ECG can be detected in any circumstance, including sleeping,” said senior author Leandro Pecchia, PhD, of the University of Warwick School of Engineering. “Our approach enables personalized tuning of detection algorithms and emphasizes how hypoglycemic events affect ECG. Based on this information, clinicians can adapt the therapy to each individual.”

Hypoglycemia can cause pronounced physiological responses as a consequence of autonomic activation, principally of the sympatho-adrenal system, which results in the release of epinephrine (adrenaline). The autonomic stimulus provokes hemodynamic changes in order maintain a supply of glucose to the brain and promote the hepatic production of glucose. Hemodynamic changes associated with hypoglycemia include an increase in heart rate and peripheral systolic blood pressure, a fall in central blood pressure, reduced peripheral arterial resistance, and an increase in myocardial contractility, stroke volume, and cardiac output.

Related Links:
University of Warwick
University of Napoli Federico II
Western University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Examination Light
Avante Vista Flex
New
Hospital Bed Mattress Cover
Skin IQ 365

Print article

Channels

Critical Care

view channel
Image: The small but powerful invention could soon make life in the NICU easier for the tiniest patients (Photo courtesy of Georgia Institute of Technology)

Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws

Newborns require frequent monitoring of their vital signs, with electrolyte levels being one of the most important indicators of their health. Currently, the only method to monitor these levels is through... Read more

Surgical Techniques

view channel
Image: Bioresorbable, 3D-printed tracheobronchial splint device (Photo courtesy of Michigan Medicine)

First-Of-Its-Kind Bioresorbable Implant to Help Children with Rare Respiratory Disease

Tracheobronchomalacia is a rare, life-threatening condition in which the cartilage in the trachea or mainstem bronchi develops abnormally, causing the airway to collapse and making breathing difficult for children.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.